Le Lézard
Classified in: Covid-19 virus

Updates to the NACHA Operating Rule Changes 2022 and Beyond Webinar - ResearchAndMarkets.com


The "Updates to the NACHA Operating Rule Changes 2022 and Beyond!"" webinar has been added to ResearchAndMarkets.com's offering.

Learn about the impacts of the ACH Contact Registration Rule

To remain in compliance with the Rules, participants in the ACH network need to ensure they are up to date on recent changes and newly approved amendments to the Rules.

Discussion on the Operations Bulletins issued by Nacha will outline the updates to different Rules with our current situation and COVID-19. Recent RFC (Request for Comment) and an RFI (Request for Information) on even more possible changes will be discussed. Included will be the most recent amendment that affects all financial institutions using the ACH Network.

This session will also cover the newly approved details and any recent updates by NACHA, plus how these changes affect you as a participant in the ACH network, whether you are an ODFI, an RDFI or a TPS or TPSP. C

hanges such as Data Security requirements (effective date has been extended) and how Originators are affected by the Fraud Detection Standards for web debits.

In addition, the processing of Unauthorized Returns has changed effective April 1, 2020 for phase 1 (phase 2 goes into effect April 1 of 2021) - As the RDFI, are you prepared for the proper use of R10 and R11 (what to do if you're not ready) and as the ODFI, are you aware of changes to the ODFI Reporting Requirements for R11 and the Unauthorized Entry Fee?

Who Should Attend:

Key Topics Covered:

For more information about this webinar visit https://www.researchandmarkets.com/r/rqxll3


These press releases may also interest you

at 06:00
The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star award to infectious diseases epidemiologist Nicole Elaine Basta at a ceremony in...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...



News published on and distributed by: